How AI can help satisfy FDA’s drug, device diversity requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.
Download STAT’s e-book to explore the challenges and steps to improve care for an aging population.
A new report suggests that the Texas man who wasinfected with bird flu virus may be the first detected case H5N1 transmitting from a mammal…
We offer free flights for patients who otherwise couldn’t get to the medical care they need. Children or adults can fly and get the care…
On May 8, join us for a conversation with practicing neurologists about overcoming current hurdles involved in diagnosing, treating, and monitoring patients in a new…
Amgen said it’s “very encouraged” by interim Phase 2 data for its obesity drug, quickly sparking investor interest. Here are the burning questions surrounding Amgen’s…
A virtual-second model can have long-term benefits across the health care system, from improving patients’ experiences to growing the telehealth market.
The Living Rare, Living Stronger NORD Patient and Family Forum will be a truly patient first event. Through it all, we will maintain our objectives:…
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a…
HomePages Pittsburgh, Pennsylvania | June 28-29, 2024 2024 FOD/OAA Family Forum Registration on Eventbrite – Click Here Wyndham Hotel Reservations – Click Here Scholarship Request…
Amgen said that it will no longer develop an early-stage obesity pill, and will instead focus on an injectable candidate that’s seen as a potential…